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Abstract
Background: There are limited data on TB among prison inmates in Bangladesh. The aim of the study was to determine the
prevalence of pulmonary tuberculosis (TB), its drug resistance and risk factors in Dhaka Central Jail, the largest prison in
Bangladesh.
Methods: Cross sectional survey with, active screening of a total number of 11,001 inmates over a period of 2 years. Sputum
samples from TB suspects were taken for acid- fast bacilli (AFB) microscopy, culture and drug susceptibility testing.
Results: Among 1,781 TB suspects 245 (13.8%) were positive for AFB on microscopy and/or culture. The prevalence rate of
sputum- positive pulmonary TB was 2,227/100,000. Fifty three cases (21.6% of 245 cases) were AFB- negative on microscopy
but were found positive on culture. Resistance to isoniazid, rifampicin, streptomycin and ethambutol was 11.4%, 0.8%,
22.4% and 6.5% respectively. No multidrug resistance was observed. The main risk factors of TB in prison were exposure
to TB patients (adjusted odds ratio 3.16, 95% CI 2.36–4.21), previous imprisonment (1.86, 1.38–2.50), longer duration
of stay in prison (17.5 months for TB cases; 1.004, 1.001–1.006) and low body mass index which is less than 18.5 kg/m
2 (5.37,
4.02–7.16).
Conclusions: The study results revealed a very high prevalence of TB in the prison population in Dhaka Central Jail. Entry
examinations and active symptom screening among inmates are important to control TB transmission inside the prison.
Identifying undiagnosed smear-negative TB cases remains a challenge to combat this deadly disease in this difficult setting.
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Introduction
Tuberculosis (TB) has been a major health problem in
penitentiary systems all over the world. The extent of TB in
prisons, which is much greater than in the community, is often
underreported. Prevalence of TB in prison is often five to 10 times
higher than the national rates [1,2,3] in some cases, by as much as
30 to 50-folds [4,5]. The high number of imprisoned persons,
extremely overcrowded conditions, inadequate ventilation, and
poor general health of inmates facilitate the spread of tuberculosis.
Prisons represent a high risk setting for development and
transmission of multidrug-resistant (MDR) TB [6]. In many
countries where the incidence of tuberculosis is very high, prisons
have been found to play a significant role in the epidemiology of
drug resistant tuberculosis [1,7,8]. Data on the prevalence of TB in
prisons in Bangladesh are limited. The Bangladesh National
Tuberculosis Control Programme (NTP) has taken initiatives to
implement directly observed treatment – short course (DOTS) in
some prisons of Bangladesh in 2002. These are the cases that come
to the outpatient service of the prison hospital seeking treatment.
Drug resistance patterns in these cases are not known as culture
and sensitivity-testing of sputum samples are not performed in the
prison setting.
The aim of this study was to determine the prevalence of TB
and drug-resistant TB in the largest prison in Bangladesh, the
Dhaka Central Jail, and to assess risk factors associated with the
development of TB among the prisoners.
Methods
The study was undertaken in the Dhaka Central Jail which is
home to about 11,000 inmates at any time although it has a
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screening system for TB before the study. We screened 11,001
inmates over a period of 24 months from October 2005 to
September 2007. A total of 11,000 inmates consented to
participate in the study. Only one inmate refused to participate;
he had access to the prison hospital that also provides diagnostic
services and treatment of TB. A medical doctor interviewed the
inmates (20–30 inmates/day), examined all TB suspects (having
cough for more than three weeks) and collected information about
risk factors for development of TB in the jail. The Dhaka Central
Jail consists of 17 building blocks. We started screening in one
block and successively completed screening in other blocks.
During the study period, inmates of all the buildings were
screened once. Fifteen buildings were visited another time for
screening the inmates except those who had already been screened
earlier. The inmates were interviewed at any point of their stay in
prison. There are two distinct areas for male and female. Among
the 11,000 inmates, 768 were female.
Three sputum samples, one spot and two early morning
samples, were collected from all suspects and brought to
International Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR,B) Tuberculosis Laboratory for acid-fast bacilli (AFB)
microscopy, culture and drug sensitivity. Diagnosis was based
upon the demonstration of AFB in sputum samples subjected to
Ziehl-Neelsen staining under light microscopy, or positive on
culture using Lo ¨wenstein-Jensen solid media. Drug sensitivity
testing was done using the proportion method [9]. The
concentrations of anti-TB drugs tested were as follows: isoniazid
0.2 mg/l, rifampicin 40 mg/l, ethambutol 2 mg/l and streptomy-
cin 4 mg/l. An isolate was considered as resistant to a particular
antibiotic when the number of colonies on the drug-containing
medium was 1% or more of the number developing on the drug-
free medium. Diagnosed TB cases were isolated and treated by the
Jail Hospital following DOTS guidelines.
The prevalence of TB in jail was defined as the number of cases
diagnosed during the study period divided by the total number of
inmates screened during that period multiplied by 100,000, and
expressed as cases per 100,000.
To determine potential risk factors for development of
pulmonary TB in jail, all screened inmates with no history of
cough exceeding three weeks were taken as controls. Data
collected for each inmate were: date of entry into the prison, date
of interview and sample collection, age, height, weight, address,
occupation, symptoms of TB, smoking, drug use, previous stay in
prison, exposure to TB patient and previous history of TB disease.
Data were entered into the computer using SPSS, version 11.5.
Odds ratios (OR) and their 95% confidence intervals (CI), were
estimated using binary logistic regression, with TB positivity as an
outcome. Univariate analyses were performed to examine the
effect of each variable on the risk of TB. Multivariate model was
then constructed, including variables that showed an effect on the
prediction of TB positivity in the univariate analyses at the
p=0.05 level of significance.
Inmates were asked about their occupation before entering the
prison. Most of them were of low socioeconomic conditions. They
were categorized as self-employed which included farmers, tailors,
hawkers etc., service where a monthly salary is paid, and, shop
owners and others engaged in the construction, garment,
transport, and export-import sectors etc. were included as
business.
The prisoners were asked about smoking and drug abuse. An
inmate was considered as smoker who took five cigarettes per day
regularly. Those who reported regular taking of Cannabis or Ganja,
Phensidyl (a liquid cough remedy), heroin, alcohol, sleeping pills
etc. at any period of their life were considered as substance
abusers. Occasional users were not included.
Body mass index (BMI) was calculated as the individual’s body
weight in kg divided by the square of their height in metre. Height
and weight of every screened inmate were taken during the
interview by using portable stadiometer and bathroom weight
scale respectively. Nutritional status was classified as severe
malnutrition (BMI,16.0), moderate malnutrition (BMI=16.0–
16.9), marginal malnutrition (BMI=17.0–18.5), normal
(BMI=18.5–24.9), and overweight (25 or more).
The study protocol was approved by the Ethics Review
Committee of ICDDR,B. All study subjects provided written
informed consent. The study staff explained to the inmates about
TB, the need for screening, the benefits of receiving treatment if
TB is detected, and the voluntary nature of participation in the
study. All questions of the inmates were answered to their
satisfaction.
Results
The study team screened 11,000 inmates (10,232 male and
768 female) over a period of 24 months; 1,781 inmates (1,685
male and 96 female) with cough of at least 3 weeks duration
were suspected to have TB. Among 1,781 suspects 192 (10.8%)
cases were positive by AFB on microscopy and 245 cases
were positive by culture. Fifty-t h r e eA F B - n e g a t i v ec a s e sw e r e
positive by culture. Only 4 confirmed cases were female. The
prevalence of sputum positive (AFB and/or culture) TB was
2,227/100,000.
Sixty-nine (n=170) percent of all strains were susceptible to all
first line antitubercular drugs and resistance to any drug was
observed in 30.6% (n=75) of strains (Table 1). Eleven percent of
the strains were resistant to INH, 0.8% were rifampicin-resistant,
22.4% were streptomycin and 6.5% were ethambutol-resistant. No
MDR TB was found in the prison population.
Most of the inmates, both TB (75.9%) and non-TB (80.2%)
subjects, were from urban areas (Table 2). Forty three percent
were categorized as self-employed and 43.6% were engaged in
business or service before imprisonment. Fifty-six percent of the
prisoners were between 21–30 yrs of age.
A number of risk factors were associated with development of
TB among the prisoners (Table 2). Those who had a history of TB
previously had three-fold higher risk than those who did not. Risk
was also three times higher among those with a history of exposure
inside as well as outside the prison. Of 130 inmates 97 (75%) had a
history of contact in prison, 26 (20%) in family and 7 (5%) in the
Table 1. Anti tuberculosis drug resistance pattern of
Mycobacterium tuberculosis isolates.
Drug Total cases n=245 Percentage (%)
Streptomycin 55 22.4
Isoniazid 28 11.4
Rifampicin 02 0.8
Ethambutol 16 6.5
Any drug 75 30.6
Any one drug 51 20.8
Any two drugs 22 9.0
Any three drugs 2 0.8
doi:10.1371/journal.pone.0010759.t001
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increased risk (1.8 times) of developing TB. Risk of having TB was
slightly higher among those who had smoked. Among the TB
cases, 85.7% had the history of taking at least 5 cigarettes per day
regularly compared to 71.4% among non-TB cases. However,
there was no risk observed among those who had used illicit drugs.
A substantial number of inmates were also found to be intravenous
drug users. Malnutrition, as defined by low BMI (,18.5), was also
associated with TB; this can either be a risk factor or result of TB.
Moderately malnourished inmates were five times more likely to
have TB. The likelihood of TB was 11 times more in inmates with
severe malnutrition (Table 2). Fifty-three percent of all TB cases
had BMI,17. Overweight inmates were less likely to have TB
(OR 0.25, 95% CI 0.34–1.80). The median duration of stay in
prison (17.5 months) was much higher for the inmates diagnosed
as having TB than that of non-TB subjects which is around 5
months (p=0.001). Longer duration of stay in prison was
associated with increased risk of developing TB among the
prisoners (Table 2).
Among the 245 TB cases identified during the 24 months
period, 37% were detected within six months of imprisonment
suggesting that a substantial number of inmates might enter the
prison with active TB or in the early stage of the disease or develop
TB within six months. Among them about 50% had a history of
previous imprisonment.
Discussion
Our study has identified a substantial number of TB cases in
Dhaka Central Jail over the 24 months period. The prevalence
rate was 2,227 per 100,000 which is over 20-fold higher than the
rate in the general population [10]. There is limited data on the
prevalence of TB from urban areas. However, in a recently done
survey, the prevalence rate of smear-positive TB in urban areas
was 49.9 per 100,000 (unpublished data). TB rates in prison in
some Asian countries were several times higher than in the general
population [1,11,12,13]. In Thailand the rate was 568/100,000
and in Pakistan it was 657/100,000 which are eight and 3.75 times
Table 2. Socio demographic characteristics of TB and non-TB cases and odds ratios (95% CI) for risk factors for tuberculosis.
Characteristics Subcategory
Inmates with
tuberculosis, n (%)
Inmates without
tuberculosis, n (%) OR (95% CI) AOR (95% CI)
Sex Male 241 (98.4) 9991 (92.9) 1.0
Female 04 (1.6) 764 (7.1) 0.22 (0.081–0.587)
Place of residence Rural 59 (24.1) 2134 (19.8)
Urban 186 (75.9) 8618 (80.2)
Age 10–20 y 16 (6.5) 1463 (13.6) 1.0
21–30 y 137 (55.9) 5833 (54.3) 2.15 (1.26–3.61)
31–40 s 63 (25.7) 2330 (21.7) 2.47 (1.42–4.29)
more than 40 y 29 (11.8) 1124 (10.5) 2.35 (1.27–4.36)
Occupation Self-employed 110 (44.9) 4599 (42.8)
Business 53 (21.6) 2220 (20.6)
Service 54 (22.0) 2296 (21.4)
Unemployed 25 (10.2) 1008 (9.4)
Housewife 3 (1.2) 630 (5.9)
Smoking No 35 (14.3) 2795 (28.6) 1.0 1.0
Yes 210 (85.7) 6981 (71.4) 2.40 (1.68–3.45) 1.42 (0.96–2.10)
History of drug abuse No 162 (66.1) 6222 (67.6)
Yes 83 (33.9) 2985 (32.4)
Previously diagnosed as TB No 185 (75.4) 9416 (96.4) 1.0 1.0
Yes 60 (24.5) 352 (3.6) 8.68 (6.36–11.83) 3.25 (2.28–4.64)
Reported weight loss (in jail) No 53 (21.6) 8903 (91.1) 1.0
Yes 192 (78.4) 870 (8.9) 37.07 (27.14–50.65)
Previous stay in prison No 158 (64.5) 7985 (81.7) 1.0 1.0
Yes 87 (35.5) 1783 (18.3) 2.47 (1.89–3.22) 1.86 (1.38–2.50)
Exposure to TB patient No 111 (46.1) 7972 (81.7) 1.0 1.0
Yes 130 (53.9) 1789 (18.3) 5.22 (4.03–6.76) 3.16 (2.36–4.21)
Duration of stay in prison (month) Median (Range) 17.50 (0.03–200.7) 5.13 (0.03–314.9) 1.006 (1.003–1.009) 1.004 (1.001–1.006)
BMI Normal (18.5–24.9) 63 (26.0) 6576 (61.3) 1.00 1.0
Overweight ($25) 01 (0.4) 495 (4.6) 0.21 (0.30–1.52) 0.25 (0.34–1.80)
Marginal (17.0–18.5) 50 (20.7) 2304 (21.5) 2.27 (1.56–3.29) 2.03 (1.38–2.98)
Moderate (16.0–16.9) 57 (23.6) 866 (8.1) 6.87 (4.77–9.90) 5.15 (3.50–7.55)
Severe (,16.0) 71 (29.3) 492 (4.6) 15.06(10.60–21.41) 10.96 (7.54–15.95)
OR=odds ratio; AOR=adjusted odds ratio; CI=confidence interval.
doi:10.1371/journal.pone.0010759.t002
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found in this study is extremely high, which needs to be addressed
immediately, and a more aggressive approach to detecting and
controlling TB in prisons is necessary.
A considerable proportion (21%) of culture-positive cases were
AFB microscopy-negative. Studies show that culture increased the
rate of detection of mycobacteria in smear negative pulmonary TB
by 25 to 38% [14,15,16,17]. Under the DOTS program only AFB
microscopy is being done. This study identified substantial number
of smear-negative culture positive tuberculosis cases, which
demonstrated that sputum culture was useful in this setting.
Facilities like culture and chest X-ray (CXR), which can be helpful
in detecting suspected smear-negative TB cases, are not available
in the prison system in Bangladesh. Most countries rely on CXR
followed by sputum analysis for suspects in prisons which is more
efficient than symptom screening alone [16]. We might have not
been able to detect some of the asymptomatic TB cases who did
not have cough for three weeks.
Drug resistance was not common in the prison; no MDR case
was identified. In many countries, where TB has been a major
heath problem in prison settings, multidrug resistance was found
to be high among both new and previously treated cases
[7,8,18,19]. The drug susceptibility results from our study will
help the NTP to formulate and implement the TB control policy
for prisons. This will improve the treatment of the TB cases in jail
also and ensure completion of treatment after release from jail.
This would prevent emergence of drug resistance and worsening of
the situation, as has occurred in prisons in many Russian, and
other countries [18,19,20,21].
Our study measured the risks associated with tuberculosis in the
prison population. The disease risk was increased for inmates who
had a previous history of suffering from TB. The average time
between the onset of recent disease, and the completion of
previous treatment was around 48 months indicating that the
increase in the number of TB cases might be largely due to
reactivation and reinfection. Our data also showed that a
considerable number (37%) of TB cases were identified during
the first six months of their stay in prison confirming that
independent of incarceration, prison inmates run a higher risk of
developing active TB than the general population, which might be
one of the main reasons for the high incidence of tuberculosis
observed in prisons. Again the disease risk was greater for persons
who stayed in the prison for longer periods and with a history of
previous imprisonment. According to our data the risk of infection
was more than three times higher among those who were living
with an inmate with TB strongly suggesting that transmission
inside the prison also contributes to the high prevalence.
Research has shown an association between malnutrition and
TB [22,23,24] and in our study we confirmed this in the prison
population in Bangladesh. The likelihood for having TB was lower
for overweight people compared to inmates with normal weight.
The very design of the study does not allow us to conclude whether
TB results in malnutrition or malnutrition predisposes to TB. But
the presence of malnutrition in such a population is an important
screening indicator of the disease in this population. Unlike what
was found in prisons in Russia [25], the use of illicit drugs was not
a risk factor associated with TB in Dhaka Central Jail.
The results of this study reveal a very high prevalence of TB in
the Dhaka Central Jail that needs to be addressed urgently. It is
evident that the spread of the disease occurs within the prison and
it is very likely that it would also spread to the community at large
after prisoners are released. Screening for TB symptoms is highly
recommended as the first line of defense in the prison. Considering
that a large group of inmates enter the prison with the disease,
srceening procedures should be in place at the time of admission
into the prison. Prisons provide a unique opportunity to srceen
and treat a population at high risk that might not otherwise have
access to medical care. This could help control the disease
effectively in the prison as well as in the community. However,
there is one difficulty in securing follow-up of TB cases who are
released before completion of their treatment. Although at the
time of release they are given a card with the treatment details and
are asked to report to their nearest DOTS centre, it remains
unknown whether they continue the treatment or not.
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